Codexis, Inc.

Healthcare

NASDAQ:CDXS · NASDAQ Global Select

Market Cap $219.06M Beta 2.48 P/E (TTM) -6.8

$2.40 -0.41%

-$0.01 today

52W Low $0.96High $3.87

Vol 0.35M · Avg 1.98M

EPS (TTM)-$0.35

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+7.62%

Period High

$3.33

Period Low

$0.98

Latest

$2.40

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Genfit S.A.

GNFT

$445.68M

C4 Therapeutics, Inc.

NASDAQ:CCCC

$323.03M

Armata Pharmaceuticals, Inc.

AMEX:ARMP

$278.27M

OmniAb, Inc.

NASDAQ:OABI

$270.34M

Innate Pharma S.A.

NASDAQ:IPHA

$165.27M

Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

$150.58M

Protara Therapeutics, Inc.

NASDAQ:TARA

$150.50M

Invivyd, Inc.

NASDAQ:IVVD

$102.20M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$64.96M

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

$49.65M

What is the latest CDXS filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does CDXS have?

Intrinsic Alpha currently shows 20 recent filings for CDXS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.